Application 209269

Type: NDA
Sponsor: EPI HLTH

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	MINOLIRA	MINOCYCLINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	EQ 105MG BASE	No	No
002	MINOLIRA	MINOCYCLINE HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	EQ 135MG BASE	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N209269-001	MINOLIRA	MINOCYCLINE HYDROCHLORIDE	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL			2017-05-08
N209269-002	MINOLIRA	MINOCYCLINE HYDROCHLORIDE	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL			2017-05-08

Orange Book patents#

Current patent rows page 1 of 1 · 2 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N209269-001	11103517	2036-04-07		Drug product	2021-09-02
N209269-002	11103517	2036-04-07		Drug product	2021-09-02

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209269-001	MINOLIRA	EQ 105MG BASE	TABLET, EXTENDED RELEASE / ORAL		2017-05-08	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N209269-002	MINOLIRA	EQ 135MG BASE	TABLET, EXTENDED RELEASE / ORAL	RS	2017-05-08	`782e0a99824c…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 66 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`782e0a99824c…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209269-001	11103517	2036-04-07	Drug product	2021-09-02	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N209269-002	11103517	2036-04-07	Drug product	2021-09-02	`6a51e52b5d6a…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 71 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Major Pharamceuticals	fd86ff45-37d0-4501-b9fb-e1836e4a8be4	2026-07-16	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Preferred Pharmaceuticals Inc.	caa99901-467c-4e99-b7e9-fbabdf5d118c	2026-07-08	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	REMEDYREPACK INC.	0becbde8-6ec5-4830-a0d9-cfdb7b15eb84	2026-07-03	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	093ff3c7-3ecc-47b4-9ae6-5218bcd262b2	2026-06-26	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	65767ae3-b1ed-4492-90f2-703b2c7e0f38	2026-06-24	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	87a137c6-dd53-44d3-ab49-ef78ebed35c8	2026-06-12	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	1ec20539-0421-4eac-95ed-e9acc6329fd0	2026-06-12	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	PD-Rx Pharmaceuticals, Inc.	7e2390b7-242c-43ff-afb3-b0a5e79351d3	2026-05-13	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	c11bfea8-6079-44ce-b8e1-20bfba631bec	2026-05-04	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	6e0efd1a-5a09-4030-8fe2-f98334cdeb0e	2026-04-22	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	9c43389b-dc98-41f3-80bf-73d916ad6843	2026-04-22	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	A-S Medication Solutions	c7d0226e-5ac5-4fb1-9849-9d6663a2e8ad	2026-04-17	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
MINOCYCLINE HYDROCHLORIDE	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	bae17358-1180-4ca8-b163-f9a6f4f83a3d	2026-04-09	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
MINOCYCLINE HYDROCHLORIDE	MINOCYCLINE HYDROCHLORIDE	Torrent Pharmaceuticals Limited	3539f84e-b489-4914-96c1-ac3731032971	2026-04-08	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Torrent Pharmaceuticals Limited	55df55fb-18ec-4e00-9ed0-10bba0da513b	2026-04-02	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	409dddb0-be3a-4ae3-ab39-88a6cd50a219	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	b3236a5c-8a5d-4d5d-9656-aee72a4c482b	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	a16012ce-5754-4177-bfb7-dcce696a7189	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	99825095-d897-4077-86df-483d505615b2	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	493bdeac-e073-4ec2-a481-85e6a6d3cb58	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
43598-539	Minolira	Minolira	Dr. Reddys Laboratories Inc	NDA	Current
43598-540	Minolira	Minolira	Dr. Reddys Laboratories Inc	NDA	Current
71403-101	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-101	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-101	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-101	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-102	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-102	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-102	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current
71403-102	Minolira Extended Release	Minocycline Hydrochloride	EPI Health, Inc	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
54737	ORIG	2018-07-02